Subsequent to Th17 cell activation, an increase in IL-17 production at the early stages of infection may benefit the infected host by (i) inducing chemokines (IL8/CXCL8) that recruit neutrophils and (ii) promoting IL-22 mediated production of defensins at the site of infection [21,22]. The gene discussed is IL17A; the disease is infection.